Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. (Q81502452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

cervix uterine cancer

1 reference

Shalini L Kulasingam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sonia Pagliusi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Evan Myers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

4 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

8110-8113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

Chapter 7: Achievements and limitations of cervical cytology screening

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Development and duration of human papillomavirus lesions, after initial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

American Cancer Society guideline for the early detection of cervical neoplasia and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.035

10.1016/J.VACCINE.2007.09.035

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961877%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference